Orange Book product · Generic (ANDA)
CELECOXIB
CELECOXIB
At a glance
Jan 12, 2021
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 12, 2021
5 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
CELECOXIB
Strength
50MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
ANDA 213301
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CELECOXIB
- 2025VYSCOXABrand (NDA)
NDA 211759 · CARWIN PHARM ASSOC
- 2020ELYXYBBrand (NDA)
NDA 212157 · SCILEX PHARMS
- 2006CELEBREXBrand (NDA)
NDA 020998 · UPJOHN
- 2025CELECOXIBGeneric (ANDA)
ANDA 205938 · ZYDUS PHARMS
- 2025CELECOXIBGeneric (ANDA)
ANDA 213127 · STRIDES PHARMA
- 2023CELECOXIBGeneric (ANDA)
ANDA 212564 · YABAO PHARM
- 2020CELECOXIBGeneric (ANDA)
ANDA 212925 · PANGEA
- 2020CELECOXIBGeneric (ANDA)
ANDA 205129 · SCIEGEN PHARMS
- 2020CELECOXIBGeneric (ANDA)
ANDA 213598 · NANJING
- 2020CELECOXIBGeneric (ANDA)
ANDA 211412 · YILING
- 2020CELECOXIBGeneric (ANDA)
ANDA 207872 · TIANJIN TIANYAO
- 2019CELECOXIBGeneric (ANDA)
ANDA 210628 · UMEDICA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
